Related Experiment Video
Updated: Mar 16, 2026
Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique
Published on: May 2, 2025
Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma
Nihal Efe1, Enver Altas, Muhammet Recai Mazlumoglu
1*Otorhinolaryngology Clinic, Paladoken State Hospital, Erzurum †Department of Otorhinolaryngology, Faculty of Medicine, Katip Celebi University, Izmir ‡Otorhinolaryngology Clinic, Hinis Sehit Yavuz Yurekseven State Hospital §Department of Otorhinolaryngology, Faculty of Medicine, Ataturk University, Erzurum ||Department of Otorhinolaryngology, Faculty of Medicine, Sitki Kocman University, Mugla ¶Department of Radiology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Abstract:
Though the lymphangioma is a benign neoplasm, it may make an invasion to vital structures by progressively growing. For lymphangioma, which progressed in such a way, surgical treatment has high morbidity and recurrence risk. On these cases, OK-432 is a frequently used sclerotherapy agent. The authors report the result they obtained by the use of single-dose OK-432 on an inoperable pediatric cervical macrocystic lymphangioma case and also their experiences.
